Pharmacokinetic comparison of a fixed-dose combination of metformin/gliclazide versus coadministration of metformin and gliclazide as separate tablets in healthy male subjects.

被引:0
|
作者
Lim, Y. [1 ]
Shin, H. [1 ]
Shim, M. [1 ]
Lim, M. [1 ]
Moon, D. [1 ]
Choi, Y. [1 ]
Lee, Y. [1 ]
Yoon, J. [1 ]
机构
[1] Chonnam Natl Univ, Med Sch & Hosp, Clin Trial Ctr, Dept Pharmacol, Kwangju, South Korea
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S61 / S61
页数:1
相关论文
共 50 条
  • [41] Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects
    Jin, Xuanyou
    Kim, Eunwoo
    Huh, Ki Young
    Hwang, Inyoung
    Cho, Joo-Youn
    Yu, Kyung-Sang
    Lee, SeungHwan
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2020, 28 (01) : 43 - 54
  • [42] Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed-Dose Combination Tablets to Canadian-Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States
    Dawra, Vikas Kumar
    Pelletier, Kathleen
    Matschke, Kyle
    Shi, Haihong
    Hickman, Anne
    Zhou, Susan
    Krishna, Rajesh
    Sahasrabudhe, Vaishali
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (05): : 510 - 520
  • [43] Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability
    de Bruin, Tjerk W. A.
    Reele, Stots
    Hamer-Maansson, Jennifer E.
    Parikh, Shamik
    Tang, Weifeng
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (02): : 118 - 130
  • [44] Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects
    Boulton, David W.
    Chang, Ming
    Griffen, Steven C.
    Kitaura, Catia
    Lubin, Susan
    Pollack, Allyson
    LaCreta, Frank
    CLINICAL THERAPEUTICS, 2016, 38 (01) : 99 - 109
  • [45] BIOEQUIVALENCE OF FIXED-DOSE COMBINATIONS OF DAPAGLIFLOZIN/METFORMIN RELATIVE TO SINGLE COMPONENTS IN HEALTHY SUBJECTS
    Boulton, D. W.
    Chang, M.
    Griffen, S. C.
    Kitaura, C.
    Lubin, S.
    Pollack, A.
    LaCreta, F.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E98 - E99
  • [46] Pharmacokinetic properties and bioequivalence of two irbesartan/hydrochlorothiazide fixed-dose combination tablets in healthy male Chinese volunteers
    Liu, Jian
    Wu, Lihua
    Hu, Xingjiang
    Wu, Guolan
    Zheng, Yunliang
    Zhou, Huili
    Zhai, You
    Zhu, Meixiang
    ShenTu, Jianzhong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (07) : 573 - 581
  • [48] Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
    Park, Jeong-Soo
    Jeon, Ji-Young
    Kim, Min-Gul
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (12) : 612 - 622
  • [49] Bioequivalence of Sitagliptin/Metformin Fixed-Dose Combination Tablets and Concomitant Administration of Sitagliptin and Metformin in Healthy Adult SubjectsA Randomized, Open-Label, Crossover Study
    Elizabeth M. Migoya
    Jutta L. Miller
    Maria Gutierrez
    Wei Zheng
    Amy O. Johnson-Levonas
    Qi Liu
    Catherine Z. Matthews
    John A. Wagner
    Keith M. Gottesdiener
    Clinical Drug Investigation, 2010, 30 : 855 - 866
  • [50] Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin - Randomized, single-blind, three-period crossover study in healthy subjects
    Hoelscher, David
    Chu, Pei-Ling
    Lyness, William
    CLINICAL DRUG INVESTIGATION, 2008, 28 (09) : 573 - 582